K-numberK243452
Device nameOrthoscan VERSA Mini C-Arm
ApplicantZiehm-Orthoscan, Inc.
Product codeOXO
Device classClass II
Decision dateJan 14, 2025
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Orthoscan VERSA Mini C-Arm is a mobile fluoroscopic X-ray system designed to provide general fluoroscopic visualization for diagnostic, surgical, and emergency care procedures on patients of all ages, including pediatric populations. It is used for imaging limbs, extremities, and shoulders in hospitals, ambulatory surgery centers, emergency departments, and physician offices.

Technological characteristics

The VERSA Mini C-Arm retains identical function to predicate devices but incorporates a Linux operating system upgrade from Ubuntu 16.04 to 20.04 for improved cybersecurity, mechanical design modifications to facilitate desktop use, revised generator printed circuit board for improved power management, alternate radiation shielding material to reduce lead environmental impact, and updated wireless footswitch communication from fixed pairing to code-hopping protocol. All core features remain unchanged: C-arm support, flat panel detector, generator, X-ray controls, workstation platform, touch screen interface, and DICOM network interfaces.

Test standards cited

The device was tested by certified laboratory and is compliant with IEC 60601-1 ED 3.2 series including IEC 60601-2-54, and meets all applicable sections of 21 CFR Subchapter J performance standards for X-ray imaging devices.

Substantial equivalence argument

The proposed modifications do not change the control mechanism, operating principle, energy type, or intended use compared to predicate devices Orthoscan TAU Mini C-Arm (K213113) and Orthoscan Mobile DI (K113708). Non-clinical testing with anthropomorphic phantoms and radiologist assessment demonstrated image quality at same or similar patient dose rates results in equivalent or slight improvement. Usability testing confirmed no previously unknown use errors or hazardous situations and no unacceptable residual risks from user interface changes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →